Rheumatoid Arthritis Trial, Recruiting NCT07524244 Sponsor: Fuller Research Foundation Condition: Rheumatoid Arthritis
Back to Rheumatoid Arthritis

Rheumatoid Arthritis Trial, Recruiting

NCT07524244
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a medically confirmed diagnosis of Inflammatory Bowel Disease (IBD) or Rheumatoid Arthritis (RA)
  • People who currently live in the continental United States
  • People who are willing and able to follow specific dietary plans as part of the study

Who may not be able to join:

  • People who are not able to give their own informed consent to participate
  • People who have Type 1 or Type 2 Diabetes and are currently taking prescription medications for it, including insulin
  • People who fall outside of the age range or body weight range set by the trial (confirm with trial site for specific numbers)
  • People without a medically confirmed diagnosis of IBD or RA
  • People with a history of strictures (narrowing of the intestine) or fistulas (abnormal connections between organs), for those with IBD
  • People who have had a blood transfusion in the past 6 months
  • People who are currently pregnant
  • People who gave birth within the last 6 months
  • People who are currently breastfeeding
  • People who are taking medications that have not been approved by the FDA
  • People who started a disease-modifying or biologic medication within the past 2 months
  • People who are unable to complete a 3-week preparatory period before the main study begins, for any reason
  • People who do not speak English
  • People who have any form of organ failure or organ disease, including of the heart, liver, or kidneys
  • People who have had a cancer diagnosis within the past year before enrolling
  • People who have an allergy to red meat or to alpha-gal (a sugar molecule found in red meat that can trigger allergic reactions)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Robert D Abbott, MD, Resilient Roots: Functional Medicine

Phone: 4342183425

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fuller Research Foundation
Registry
ClinicalTrials.gov
Start date
17 February 2026
Est. completion
1 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in health-related quality of life measured using the 36-Item Short Form Health Survey (SF-36); Change in health-related quality of life measured using the 36-Item Short Form Health Survey (SF-36)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov